Zenodo
What treatment should be considered for a patient with chronic HBV who is anti-HDV positive?
By Tripdatabase.
Abstract
Bulevirtide is currently the preferred treatment for patients with chronic HBV who are anti-HDV positive. While pegylated interferon may be used in combination for suboptimal responders, bulevirtide's efficacy and safety profile make it the primary choice.
Keywords
- Hepatitis B Virus Studies
- chronic hepatitis B
- bulevirtide
- pegylated interferon
- combination therapy
- treatment selection
- antiviral therapy
- Open access